Focal Adhesion Kinase Provides a Collateral Vulnerability That Can Be Leveraged to Improve Mtorc1 Inhibitor Efficacy.
Cancers（2022）
Key words
triple negative breast cancer,TNBC,mTORC1,FAK,focal adhesion kinase,rapamycin,defactinib,intrinsic resistance,collateral sensitivity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined